BET-IN-19
BET-IN-19 (Compound 146) is a BET inhibitor. BET-IN-19 inhibits hlL-6 mRNA transcription (IC50 ≤0.3 uM), and c-myc activity in human AML MV4-11 cell (IC50 ≤0.3 uM) 。BET-IN-19 inhibits tetra-acetylated histone H4 binding to BRD4 bromodomain 1 (IC50 ≤0.3 uM) [1].
Product Specifications
CAS Number
1643947-30-1
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bet-in-19.html
Purity
99.74
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CNC1=NC(N=CC(C2=C(C)ON=C2C)=C3)=C3N1CC4=CC=CC=C4
Molecular Formula
C19H19N5O
Molecular Weight
333.39
References & Citations
[1]Bryan Cordell DUFFY, et al. Novel bicyclic bromodomain inhibitors. Patent. WO2015002754 A2.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HA751442 100 µL
Antithrombin III / ATIII Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
AN301411L-01 50 µL
Recombinant Histone H4 (Acetyl Lys12) Monoclonal Antibody
Sign In for Pricing
View Details AN301411L-02 100 µL
Recombinant Histone H4 (Acetyl Lys12) Monoclonal Antibody
Sign In for Pricing
View Details 
